Citations

Mayo Clinic

Showing 10 of 108245 citations.

O1–04–01: Quantitative evaluation of PIB PET and FDG PET in early cognitive impairment
Lowe, Val J. , Kemp, Brad , Petersen, Ronald C. , Jack, Clifford R. , Mathis, Chester A. , Klunk, William E.

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.077 Get It

O1–05–03: PET measurements of posterior cingulate glucose metabolism are superior to MRI measurements of hippocampal volume in distinguishing cognitively normal persons at differential genetic risk for Alzheimer's disease
Reiman, Eric M. , Alexander, Gene E. , Reschke, Cole, Lee, Wendy , Smilovici, Oded, Buckley, Shannon, Sacrey, Diana Truran, Schuff, Norbert, Müller, Stig , Weiner, Michael W. , Caselli, Richard J., Chen, Kewei , Smilovici, Oded

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.070 Get It

S2–01–01: Role of vascular risk factors in cognitive decline beginning in middle age
Coker, Laura H., Knopman, David S. , Catellier, Diane , Mosley, Thomas H.

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.059 Get It

O2–02–07: Hippocampal diffusivity on DTI differ between amnestic and non‐amnestic MCI
Avula, Ramesh, Przybelski, Scott A. , Weigand, Stephen D. , Petersen, Ronald C. , Kantarci, Kejal , Boeve, Bradley F. , Knopman, David S. , Smith, Glenn E. , Vemuri, Prashanthi , Jack, Clifford R.

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.041 Get It

O2–02–01: Patterns of atrophy on voxel based morphometry differ between amnestic MCI converters and nonconverters
Whitwell, Jennifer L. , Weigand, Stephen D. , Przybelski, Scott A. , Petersen, Ronald C. , Boeve, Bradley F. , Knopman, David S. , Jack, Clifford R.

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.035 Get It

O2–03–03: Selective T1‐weighted enhancement of individual Alzheimer's disease amyloid plaques using an antibody fragment against Aβ42 as a magnetic resonance molecular imaging contrast agent
Poduslo, Joseph F., Ramakrishnan, Muthu, Wengenack, Thomas M., Curran, Geoffry L., Gilles, Emily J., Kandimalla, Karunya K. , Ramı́rez-Alvarado, Marina , Garwood, Michael , Jack, Clifford R.

Alzheimer's & Dementia | June 4, 2007 | Volume: 3 | Issue: 3S_Part_3 | Pages: No page available

10.1016/j.jalz.2007.04.028 Get It

Platelet-Derived Growth Factor Receptor β–Mediated Phosphorylation of MUC1 Enhances Invasiveness in Pancreatic Adenocarcinoma Cells
Singh, Pankaj K. , Wen, Yunfei, Swanson, Benjamin J., Shanmugam, Kandavel , Kazlauskas, Andrius , Cerny, Ronald L. , Gendler, Sandra , Hollingsworth, Michael A.

Cancer Research | June 1, 2007 | Volume: 67 | Issue: 11 | Pages: 5201-5210

10.1158/0008-5472.can-06-4647 | PMID 17545600 Get It

Abstract MUC1 is a heterodimeric transmembrane glycoprotein that is overexpressed and aberrantly glycosylated in ductal adenocarcinomas. Differential phosphorylation of the MUC1 cytoplasmic tail (MUC1CT) has been associated with signaling events that influence the proliferation and metastasis of cancer cells. We identified a novel tyrosine phosphorylation site (HGRYVPP) in the MUC1CT by mass spectrometric analysis of MUC1 from human pancreatic adenocarcinoma cell lines. Analyses in vitro and in vivo showed that platelet-derived growth factor receptor β (PDGFRβ) catalyzed phosphorylation of this site and of tyrosine in the RDTYHPM site. Stimulation of S2-013.MUC1F cells with PDGF-BB increased nuclear colocalization of MUC1CT and β-catenin. PDGF-BB stimulation had no significant effect on cell proliferation rate; however, it enhanced invasion in vitro through Matrigel and in vivo tumor growth and metastases. Invasive properties of the cells were significantly altered on expression of phosphorylation-abrogating or phosphorylation-mimicking mutations at these sites. We propose that interactions of MUC1 and PDGFRβ induce signal transduction events that influence the metastatic properties of pancreatic adenocarcinoma. [Cancer Res 2007;67(11):5201–10]
Extending Jak2V617F and MplW515 Mutation Analysis to Single Hematopoietic Colonies and B and T Lymphocytes
Pardanani, Animesh , Finke, Christy M. , Ketterling, Rhett P. , Gilliland, Dwight Gary, Tefferi, Ayalew , Lasho, Terra L. , Mesa, Ruben A. , Hogan, William J. , Ketterling, Rhett P

Stem Cells | June 1, 2007 | Volume: 25 | Issue: 9 | Pages: 2358-2362

10.1634/stemcells.2007-0175 | PMID 17540852 Get It

Abstract JAK2V617F and MPLW515L/K are myeloproliferative disorder (MPD)-associated mutations. We genotyped 552 individual hematopoietic colonies obtained by CD34+ cell culture from 16 affected patients (13 JAK2V617F and 3 MPLW515L/K) to determine (a) the proportion of colonies harboring a particular mutation in the presence or absence of cytokines, (b) the lineage distribution of endogenous colonies for each mutation, and (c) the differences (if any) in the pattern of mutation among the various MPDs, as established by genotyping of individual colonies. Genotyping analysis revealed cohabitation of mutation-negative and mutation-positive endogenous colonies in polycythemia vera as well as other MPDs. Culture of progenitor cells harboring MPLW515L/K yielded virtually no endogenous erythroid colonies in contrast to JAK2V617F-harboring progenitor cells. The mutation pattern (i.e., relative distribution of homozygous, heterozygous, or wild-type colonies) was not a distinguishing feature among the MPDs, and MPLW515 mutations were detected in B and/or T lymphocytes in all three patients tested. These observations suggest that clonal myelopoiesis antedates acquisition of JAK2V617F or MPLW515L/K mutations and that the latter is acquired in a lympho-myeloid progenitor cell. Disclosure of potential conflicts of interest is found at the end of this article.
Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Can
Olsen, Elise A. , Vonderheid, Eric C. , Pimpinelli, Nicola , Knobler, Robert , Zackheim, Herschel, Estrach, Teresa , Lamberg, Stanford, Wood, Gary S. , Dummer, Reinhard , Burg, Günter , Heald, Peter, Pittelkow, Mark R. , Bernengo, M.G., Sterry, Wolfram, Laroche, L. , Trautinger, Franz , Whittaker, Sean , Willemze, Rein , Kim, Youn , Zackheim, Herschel, Duvic, Madeleine , Lamberg, Stanford, Ranki, Annamari , Sterry, Wolfram

Blood | May 31, 2007 | Volume: 110 | Issue: 6 | Pages: 1713-1722

10.1182/blood-2007-03-055749 | PMID 17540844 Get It

Abstract The ISCL/EORTC recommends revisions to the Mycosis Fungoides Cooperative Group classification and staging system for cutaneous T-cell lymphoma (CTCL). These revisions are made to incorporate advances related to tumor cell biology and diagnostic techniques as pertains to mycosis fungoides (MF) and Sézary syndrome (SS) since the 1979 publication of the original guidelines, to clarify certain variables that currently impede effective interinstitution and interinvestigator communication and/or the development of standardized clinical trials in MF and SS, and to provide a platform for tracking other variables of potential prognostic significance. Moreover, given the difference in prognosis and clinical characteristics of the non-MF/non-SS subtypes of cutaneous lymphoma, this revision pertains specifically to MF and SS. The evidence supporting the revisions is discussed as well as recommendations for evaluation and staging procedures based on these revisions.
Contribution of In Vivo Structural Measurements and Load/Strength Ratios to the Determination of Forearm Fracture Risk in Postmenopausal Women
Melton, L. Joseph, Riggs, B. Lawrence, Lenthe, Harry van , Achenbach, Sara J., Müller, Ralph , Bouxsein, Mary , Amin, Shreyasee , Atkinson, Elizabeth J. , Khosla, Sundeep , Khosla, Sundeep

Journal of Bone and Mineral Research | May 31, 2007 | Volume: 22 | Issue: 9 | Pages: 1442-1448

10.1359/jbmr.070514 | PMID 17539738 Get It

Abstract Bone structure, strength, and load-strength ratios contribute to forearm fracture risk independently of areal BMD. Introduction: Technological and conceptual advances provide new opportunities for evaluating the contributions of bone density, structure, and strength to the pathogenesis of distal forearm fractures. Materials and Methods: From an age-stratified random sample of Rochester, MN, women, we compared 18 with a distal forearm fracture (cases) to 18 age-matched women with no osteoporotic fracture (controls). High-resolution pQCT was used to assess volumetric BMD (vBMD), geometry, and microstructure at the ultradistal radius, the site of Colles' fractures. Failure loads in the radius were estimated from microfinite element (μFE) models derived from pQCT. Differences between case and control women were assessed, and the risk of fracture associated with each variable was estimated by logistic regression analysis. Results: Given similar heights, estimated loading in a fall on the outstretched arm was the same in cases and controls. However, women with forearm fractures had inferior vBMD, geometry, microstructure, and estimated bone strength. Relative risks for the strongest determinant of fracture in each of the five main variable categories were as follows: BMD (total vBMD: OR per SD change, 4.2; 95% CI, 1.4–12), geometry (cortical thickness: OR, 4.0; 95% CI, 1.4–11), microstructure (trabecular number: OR, 2.3; 95% CI, 1.02–5.1), and strength (axial rigidity: OR, 3.8; 95% CI, 1.4–10); the factor-of-risk (fall load/μFE failure load) was 24% greater (worse) in cases (OR, 3.0; 95% CI, 1.2–7.5). Areas under ROC curves ranged from 0.72 to 0.82 for these parameters. Conclusions: Bone geometry, microstructure, and strength contribute to forearm fractures, as does BMD, and these additional determinants of risk promise greater insights into fracture pathogenesis.